Overall, in this study, we explored predictive markers for the efficacy of eradication therapy against gastric MALT lymphoma that was negative for both the API2-MALT1 fusion gene and Hp infection. The gene discussed is MALT1; the disease is gastric mucosa-associated lymphoid tissue lymphoma.